Angela Follett, Ph.D. is a principal in Fish’s Twin Cities office where she focuses her national practice on patent prosecution, portfolio development advice, and strategic patent counseling. Dr. Follett has extensive expertise in the areas of small molecule pharmaceuticals, drug formulations, drug delivery, new methods of treatment, biopharmaceuticals, small molecules (including inorganic or metal-containing small molecules), imaging agents, nanotechnologies, nutraceutical formulations, agricultural formulations, and green/environmental chemistries. Dr. Follett received her J.D., magna cum laude, from the University of St. Thomas in 2011, her Ph.D. in chemistry from the University of Minnesota in 2006, and her B.A., magna cum laude, Phi Beta Kappa, in chemistry and biochemistry from Gustavus Adolphus College in 2001. View Dr. Follett’s Women Worth Watching in STEM profile.
Lisa Greenwald-Swire is a principal in the firm’s Silicon Valley office where she focuses her practice on global trademark counseling and prosecution including brand strategy, strategic portfolio development, licensing, and trademark rights on the Internet. Greenwald-Swire also has extensive experience handling global enforcement programs and opposition and cancellation proceedings before the Trademark Trial and Appeal Board (TTAB). She has managed numerous trademark and copyright infringement matters in federal district court and has successfully resolved domain name disputes under the Uniform Domain-Name Dispute-Resolution Policy (UDRP). Greenwald-Swire received her J.D., cum laude, from Georgetown University Law Center in 1999 and her B.A., Phi Beta Kappa, Phi Kappa Phi, Sigma Iota Rho, Pi Sigma Alpha, from the University of Michigan in 1994. View Greenwald-Swire’s Women Worth Watching in STEM profile.
Tiffany Reiter, Ph.D. is a principal in the firm’s Boston office. Dr. Reiter’s practice emphasizes U.S. and foreign patent prosecution, opinion work, due diligence studies, and portfolio advisement. Technical areas of her prosecution and opinion work include molecular biology, biochemistry and biochemical pathways, genetics, cellular biology, virology, recombinant protein manufacturing, nucleic acid vectors and RNAi, chromatin remodeling, array technology, immunology, recombinant antibody screening and engineering, molecular medicine, screening and diagnostic assays and kits, biomarkers, transgenic plants and animals, cell lines, nanoparticle technology, surgical procedures, vaccines, and neuroscience. Dr. Reiter received her J.D. from Suffolk University Law School in 2012, her Ph.D. in molecular biology from Mayo Graduate School in 2002, and her B.S., summa cum laude, in biotechnology from St. Cloud State University in 1997. View Dr. Reiter’s Women Worth Watching in STEM profile.
Jenny Shmuel, Ph.D. is a principal in the firm’s Boston office where she focuses on patent litigation with an emphasis on medical device and pharmaceutical technologies. She has represented pharmaceutical clients in competitor litigation, Hatch-Waxman litigation, and biosimilar litigation. Over the last several years, Dr. Shmuel has helped successfully defend Gilead’s HCV franchise and secured a significant damages award for a medical device manufacturer. She regularly authors blogs and presents webinars on hot topics in biosimilar litigation. Her doctoral work focused on biological applications for polymer thin films. Dr. Shmuel received her J.D., cum laude, from Harvard Law School in 2012 and her B.S. (2004) and Ph.D. (2009) in materials science and engineering from the Massachusetts Institute of Technology. View Dr. Shmuel’s Women Worth Watching in STEM profile.
Profiles in Diversity Journal is dedicated to promoting and advancing diversity and inclusion in the corporate, government, nonprofit, higher education, and military sectors.